caffeic acid phenethyl ester has been researched along with indirubin in 3 studies
| Studies (caffeic acid phenethyl ester) | Trials (caffeic acid phenethyl ester) | Recent Studies (post-2010) (caffeic acid phenethyl ester) | Studies (indirubin) | Trials (indirubin) | Recent Studies (post-2010) (indirubin) |
|---|---|---|---|---|---|
| 840 | 1 | 469 | 347 | 3 | 184 |
| Protein | Taxonomy | caffeic acid phenethyl ester (IC50) | indirubin (IC50) |
|---|---|---|---|
| Glycogen synthase kinase-3 beta | Sus scrofa (pig) | 1 | |
| [Tau protein] kinase | Sus scrofa (pig) | 1 | |
| Cyclin-dependent kinase 14 | Homo sapiens (human) | 2.2 | |
| G2/mitotic-specific cyclin-B2 | Homo sapiens (human) | 8.25 | |
| Epidermal growth factor receptor | Homo sapiens (human) | 2 | |
| Insulin receptor | Homo sapiens (human) | 2 | |
| Cyclin-dependent kinase 1 | Homo sapiens (human) | 7.74 | |
| Cyclin-dependent kinase 4 | Homo sapiens (human) | 2.2 | |
| G2/mitotic-specific cyclin-B1 | Homo sapiens (human) | 8.8333 | |
| G2/mitotic-specific cyclin-B | Marthasterias glacialis (spiny starfish) | 1 | |
| Cyclin-A2 | Homo sapiens (human) | 3.525 | |
| Cyclin-dependent kinase 11B | Homo sapiens (human) | 2.2 | |
| Kit ligand | Homo sapiens (human) | 2 | |
| G1/S-specific cyclin-E1 | Homo sapiens (human) | 4.85 | |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | 3.24 | |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 2 | |
| Cyclin-dependent kinase 8 | Homo sapiens (human) | 2.2 | |
| Glycogen synthase kinase-3 alpha | Homo sapiens (human) | 1.5 | |
| Glycogen synthase kinase-3 beta | Homo sapiens (human) | 0.8515 | |
| Cyclin-dependent kinase 7 | Homo sapiens (human) | 2.2 | |
| Cyclin-dependent kinase 9 | Homo sapiens (human) | 2.2 | |
| Cyclin-dependent kinase 3 | Homo sapiens (human) | 2.2 | |
| Cyclin-dependent kinase 6 | Homo sapiens (human) | 2.2 | |
| Cyclin-dependent-like kinase 5 | Homo sapiens (human) | 6.15 | |
| Cyclin-dependent kinase 16 | Homo sapiens (human) | 2.2 | |
| Cyclin-dependent kinase 17 | Homo sapiens (human) | 2.2 | |
| Cyclin-dependent kinase 18 | Homo sapiens (human) | 2.2 | |
| Cyclin-dependent kinase 13 | Homo sapiens (human) | 2.2 | |
| Cyclin-dependent kinase 5 activator 1 | Homo sapiens (human) | 6.7143 | |
| Cyclin-dependent kinase 10 | Homo sapiens (human) | 2.2 | |
| Cyclin-dependent kinase 20 | Homo sapiens (human) | 2.2 | |
| G2/mitotic-specific cyclin-B3 | Homo sapiens (human) | 8.25 | |
| Cyclin-dependent kinase 15 | Homo sapiens (human) | 2.2 | |
| Cyclin-dependent kinase 19 | Homo sapiens (human) | 2.2 | |
| Cyclin-dependent kinase 1 | Oryzias latipes (Japanese medaka) | 1 | |
| Cyclin-dependent kinase 12 | Homo sapiens (human) | 2.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, W; Hao, Y; Hu, P; Ma, D; Pan, H; Xie, X; Yu, AD; Yu, J; Yuan, J; Zhang, L; Zhu, H | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Fallarero, A; Hanski, L; Isojärvi, J; Karhu, E; Vuorela, P | 1 |
3 other study(ies) available for caffeic acid phenethyl ester and indirubin
| Article | Year |
|---|---|
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
Topics: Autophagy; Calcium Channel Blockers; Cell Line, Tumor; Drug Evaluation, Preclinical; Fluspirilene; Glioblastoma; Green Fluorescent Proteins; Humans; Intracellular Membranes; Loperamide; Microtubule-Associated Proteins; Mycotoxins; Peptides; Phagosomes; Phosphatidylinositol Phosphates; Pimozide; Protein Kinases; Recombinant Fusion Proteins; Sirolimus; Small Molecule Libraries; TOR Serine-Threonine Kinases; Trifluoperazine; Zinc Fingers | 2007 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Identification of Privileged Antichlamydial Natural Products by a Ligand-Based Strategy.
Topics: Anti-Bacterial Agents; Azithromycin; Biological Products; Cell Line; Cell Survival; Chlamydophila pneumoniae; Drug Discovery; Humans; Ligands; Microbial Sensitivity Tests; Molecular Structure | 2017 |